Cerevel Therapeutics
CERE
$42.31
Share price
0.17%
Change (1 day)
31.77%
Change (1 year)
Categories
Market capitalization of Cerevel Therapeutics (CERE)
Market cap: $7.70 Billion
As of May 2024 Cerevel Therapeutics has a market cap of $7.70 Billion. This makes Cerevel Therapeutics the world's 2010th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Cerevel Therapeutics from 2020 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $7.70 B | 0.65% |
| 2023 | $7.65 B | 55.34% |
| 2022 | $4.93 B | 3.29% |
| 2021 | $4.77 B | 126.47% |
| 2020 | $2.10 B |
End of Day market cap according to different sources
On May 14th, 2024 the market cap of Cerevel Therapeutics was reported to be:
$7.69 Billion
$7.69 Billion
$7.69 Billion
$7.69 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Archer Daniels Midland (ADM)
ADM | $30.62 B | 297.28% | 🇺🇸 USA |
 Campbell Soup CPB | $13.81 B | 79.20% | 🇺🇸 USA |
 Dow DOW | $42.06 B | 445.69% | 🇺🇸 USA |
 Dupont De Nemours DD | $33.16 B | 330.18% | 🇺🇸 USA |